Claim/exemption information - Registry number 3725082

Case number
2025-003768
Claimant name
Advancing Chemistry Inc.
Product identifier
HSC-329
Claim type
Original
Date of filing
Claim validity status
Valid
Claim validity decision date
Exemption expiry date
Non-compliance(s) identified on SDS and/or label
Yes, Order issued
SDS and/or label compliance review decision date
Claim/exemption status
Active

Additional information

Date of the order
Order status
Unresolved

List of suggested corrective measures

  • Disclose all applicable hazard classifications for the product (see appendix 2).

  • Disclose an adequate odour.

  • Disclose either the name of the symbol or the symbol itself for each of the applicable product hazard classifications, specifically for “Skull and crossbones”.

  • Disclose either the name of the symbol or the symbol itself for each of the applicable product hazard classifications, specifically “Skull and crossbones”.

  • Disclose the HMIRA registry number and correct date of decision granting the exemption.

  • Disclose the appropriate hazard classification information.

  • Disclose the appropriate product flammability under subheading "Flammability".

  • Disclose the auto-ignition temperature.

  • Disclose the following incompatible materials: Oxidants (chromium trioxide, perchloric acid, potassium dichromate, sodium hypochlorite) [14].

  • Disclose the hazard statements for each of the product hazard classification categories or subcategories (see appendix 3).

  • Disclose the other hazards known to the supplier with respect to the hazardous product.

  • Disclose the partition coefficient – n-octanol/water.

  • Disclose the percent of unknown acute oral toxicity, percent of unknown acute dermal toxicity and percent of unknown acute inhalation toxicity.

  • Disclose the percent of unknown acute oral toxicity, percent of unknown acute dermal toxicity, and percent of unknown acute inhalation toxicity.

  • Disclose the precautionary statements for each of the product hazard classification categories or subcategories (see appendix 3).

  • Disclose the product identifier listed on the SDS and application form.

  • Disclose the product oral, inhalation and dermal acute toxicity estimates (ATEs).

  • Disclose the relevant conditions for safe storage (see appendix 4).

  • Disclose the relevant precautions for safe handling (see appendix 4).

  • Disclose the signal word “Danger”.

  • Disclose, across applicable sections of the SDS, consistent information related to precautionary statements disclosed in section 2 (see appendix 1).

  • Remove all forward slashes or diagonal marks in precautionary statements for which a choice is to be made.

Date modified: